GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death in adults who had an initial stroke, according to a preliminary study to be presented at the American Heart Association’s Scientific Sessions 2024.
Patients More Satisfied With AI’s Answers Than Those From Their Doctor
Patients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their
October 26, 2024